melanotic race COM April 2005 Diagnosis Ocular melanomas and melanocytic lesions

What has been intriguing are small clinical trials that suggest some responses, but with no clear rationale for why cancers should respond to vitamin C or a path forward for explaining which patients are most likely to respond

In this tumor, the transformation of normal melanocytes into melanoma cells is a multistep process (Albino et al., 1991

JBB is an investigator and/or consultant without any direct financial benefit under contracts between his employer and the following companies: Andromeda, Astra-Zeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Elcelyx, Eli Lilly, GI Dynamics, GlaxoSmithKline, Halozyme Therapeutics, Hoffmann-La Roche, Intarcia, Johnson & Johnson, Lexicon, LipoScience, Medtronic, Merck, Metabolon, Metavention, Novo Nordisk, Orexigen Therapeutics, Osiris Therapeutics, Pfizer, Quest Diagnostics, Rhythm Pharmaceuticals, Sanofi, Spherix, Takeda, ToleRx and TransTech Pharma

however, confidence in these findings is limited by heterogeneity, open-label designs, and short treatment durations